Bradbury Daniel
Director at CSTL; Director at ILMN; Director at CORT, and 1 more
- Sold, on record
- $182M
- Dollars the filings state
- Form 4 sales
- 170
- Latest Feb 5, 2025
- Form 144 notices
- 5
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- CSTLCASTLE BIOSCIENCES INCDirector
- ILMNILLUMINA, INC.Director
- CORTCORCEPT THERAPEUTICS INCDirector
- AMYLIN PHARMACEUTICALS INCPresident & Chief Executive Of
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- CSTL969,575 shares
- ILMN173,100 shares
- CORT140,000 shares
- AMYLIN PHARMACEUTICALS INC85,198 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CSTLRoutineAug 12 2024
Sold 7,883 shares at $26.65 ($210k)
Bradbury Daniel, Director
10b5-1 planSold 48% of holdings ($438k position)8,550 shares left1x usual sizeFiling
- 2 Form 4 sale CSTLRoutineSep 5 +24 days
Sold 7,867 shares at $29.02 ($228k)
Bradbury Daniel, Director
10b5-1 planSold 52.5% of holdings ($435k position)7,125 shares left1x usual sizeFiling
- 3 Form 4 sale CSTLRoutineOct 7 +32 days
Sold 7,867 shares at $29.44 ($232k)
Bradbury Daniel, Director
10b5-1 planSold 58% of holdings ($399k position)5,700 shares left1x usual sizeFiling
- 4 Form 4 sale CSTLRoutineNov 1 +25 days
Sold 7,867 shares at $34.73 ($273k)
Bradbury Daniel, Director
10b5-1 planSold 64.8% of holdings ($422k position)4,275 shares left1x usual sizeFiling
- 5 Form 144 notice CSTLNoticeDec 3 +32 days
Filed to sell 15,734 shares ($484k)
Bradbury Daniel, Officer
10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale CSTLRoutineDec 3 same day
Sold 7,867 shares at $30.98 ($244k)
Bradbury Daniel, Director
10b5-1 planSold 73.4% of holdings ($332k position)2,850 shares leftFirst sale on recordFollows a Form 144Filing
- 7 Form 4 sale CSTLRoutineJan 6 +34 days
Sold 7,867 shares at $29.14 ($229k)
Bradbury Daniel, Director
10b5-1 planSold 84.7% of holdings ($271k position)1,425 shares left1x usual sizeFiling
- 8 Form 4 sale CSTLRoutineFeb 5 +30 days
Sold 7,867 shares at $28.17 ($222k)
Bradbury Daniel, Director
10b5-1 planSold 100% of holdings ($222k position)0 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (175)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | CSTL | Director | Form 4 sale | 7,867 | $222k | 100.0% | Routine | SEC |
| Jan 6, 2025 | CSTL | Director | Form 4 sale | 7,867 | $229k | 84.7% | Routine | SEC |
| Dec 3, 2024 | CSTL | Director | Form 4 sale | 7,867 | $244k | 73.4% | Routine | SEC |
| Dec 3, 2024 | CSTL | Officer | Form 144 notice | 15,734 | $484k | Notice | SEC | |
| Nov 1, 2024 | CSTL | Director | Form 4 sale | 7,867 | $273k | 64.8% | Routine | SEC |
| Oct 7, 2024 | CSTL | Director | Form 4 sale | 7,867 | $232k | 58.0% | Routine | SEC |
| Sep 5, 2024 | CSTL | Director | Form 4 sale | 7,867 | $228k | 52.5% | Routine | SEC |
| Aug 12, 2024 | CSTL | Director | Form 4 sale | 7,883 | $210k | 48.0% | Routine | SEC |
| May 6, 2024 | CSTL | Director | Form 4 sale | 23,323 | $575k | 70.0% | Unusual | SEC |
| Apr 8, 2024 | CSTL | Director | Form 4 sale | 2,400 | $49k | 11.8% | Routine | SEC |
| Apr 5, 2024 | CSTL | Director | Form 4 sale | 20,923 | $442k | 52.7% | Routine | SEC |
| Mar 4, 2024 | CSTL | Director | Form 4 sale | 23,323 | $482k | 47.4% | Unusual | SEC |
| Feb 7, 2024 | CSTL | Director | Form 4 sale | 2,074 | $48k | 5.8% | Routine | SEC |
| Feb 6, 2024 | CSTL | Director | Form 4 sale | 21,249 | $494k | 38.1% | Routine | SEC |
| Jan 5, 2024 | CSTL | Director | Form 4 sale | 23,323 | $476k | 35.8% | Routine | SEC |
| Dec 13, 2023 | CSTL | Director | Form 4 sale | 2,368 | $47k | 4.5% | Routine | SEC |
| Dec 8, 2023 | CSTL | Director | Form 4 sale | 6,875 | $138k | 12.0% | Routine | SEC |
| Dec 6, 2023 | CSTL | Director | Form 4 sale | 200 | $4k | 0.4% | Routine | SEC |
| Dec 4, 2023 | CSTL | Director | Form 4 sale | 13,885 | $279k | 20.7% | Routine | SEC |
| Dec 1, 2023 | CSTL | Other: Affiliate | Form 144 notice | 46,651 | $932k | Notice | SEC | |
| Nov 30, 2023 | CSTL | Director | Form 4 sale | 29,521 | $594k | 33.8% | Unusual | SEC |
| Nov 24, 2023 | CSTL | Director | Form 4 sale | 800 | $16k | 1.2% | No plan | SEC |
| Nov 21, 2023 | CSTL | Director | Form 4 sale | 6,055 | $121k | 8.7% | No plan | SEC |
| Nov 20, 2023 | CSTL | Other: Affiliate | Form 144 notice | 86,280 | $1.7M | Notice | SEC | |
| Sep 1, 2023 | CSTL | Director | Form 4 sale | 1,802 | $36k | 2.7% | No plan | SEC |
| Aug 31, 2023 | CSTL | Director | Form 4 sale | 11,918 | $239k | 15.4% | No plan | SEC |
| Jul 7, 2023 | CSTL | Director | Form 4 sale | 50,000 | $1M | 42.4% | Unusual | SEC |
| Jul 7, 2023 | CSTL | Affiliate | Form 144 notice | 75,000 | $1.5M | Notice | SEC | |
| May 5, 2023 | CSTL | Director | Form 4 sale | 25,000 | $541k | 24.3% | No plan | SEC |
| May 4, 2023 | CSTL | Affiliate | Form 144 notice | 50,000 | $1.1M | Notice | SEC | |
| Apr 5, 2023 | CSTL | Director | Form 4 sale | 7,100 | $158k | 7.9% | Routine | SEC |
| Apr 4, 2023 | CSTL | Director | Form 4 sale | 17,900 | $397k | 17.5% | Routine | SEC |
| Mar 3, 2023 | CSTL | Director | Form 4 sale | 25,000 | $599k | 22.2% | Plan not stated | SEC |
| Feb 2, 2023 | CSTL | Director | Form 4 sale | 25,000 | $687k | 21.2% | Plan not stated | SEC |
| Jan 3, 2023 | CSTL | Director | Form 4 sale | 7,704 | $176k | 3.7% | Plan not stated | SEC |
| Dec 1, 2022 | CSTL | Director | Form 4 sale | 7,704 | $185k | 3.6% | Plan not stated | SEC |
| Nov 1, 2022 | CSTL | Director | Form 4 sale | 7,704 | $196k | 3.5% | Plan not stated | SEC |
| Oct 3, 2022 | CSTL | Director | Form 4 sale | 7,704 | $209k | 3.3% | Plan not stated | SEC |
| Sep 1, 2022 | CSTL | Director | Form 4 sale | 7,704 | $216k | 3.2% | Plan not stated | SEC |
| Aug 1, 2022 | CSTL | Director | Form 4 sale | 7,704 | $212k | 3.1% | Plan not stated | SEC |
| Mar 30, 2022 | CSTL | Director | Form 4 sale | 17,704 | $799k | 15.4% | Plan not stated | SEC |
| Mar 15, 2022 | CSTL | Director | Form 4 sale | 17,704 | $662k | 14.7% | Plan not stated | SEC |
| Feb 23, 2022 | CSTL | Director | Form 4 sale | 17,704 | $693k | 14.1% | Plan not stated | SEC |
| Feb 10, 2022 | CSTL | Director | Form 4 sale | 17,704 | $814k | 13.6% | Plan not stated | SEC |
| Jan 24, 2022 | CSTL | Director | Form 4 sale | 14,631 | $518k | 11.1% | Plan not stated | SEC |
| Jan 20, 2022 | CSTL | Director | Form 4 sale | 15,604 | $550k | 11.4% | Plan not stated | SEC |
| Jan 18, 2022 | CSTL | Director | Form 4 sale | 2,470 | $87k | 1.9% | Plan not stated | SEC |
| Jan 5, 2022 | CSTL | Director | Form 4 sale | 32,706 | $1.4M | 20.6% | Unusual | SEC |
| Nov 8, 2021 | CSTL | Director | Form 4 sale | 5,554 | $340k | 3.9% | Plan not stated | SEC |
| Nov 4, 2021 | CSTL | Director | Form 4 sale | 4,446 | $271k | 3.2% | Plan not stated | SEC |
| Oct 22, 2021 | CSTL | Director | Form 4 sale | 10,000 | $628k | 6.8% | Plan not stated | SEC |
| Oct 5, 2021 | CSTL | Director | Form 4 sale | 10,000 | $617k | 6.7% | Plan not stated | SEC |
| Sep 22, 2021 | CSTL | Director | Form 4 sale | 10,000 | $743k | 6.5% | Plan not stated | SEC |
| Sep 9, 2021 | CSTL | Director | Form 4 sale | 10,000 | $766k | 6.4% | Plan not stated | SEC |
| Aug 18, 2021 | CSTL | Director | Form 4 sale | 10,000 | $611k | 6.3% | Plan not stated | SEC |
| Aug 4, 2021 | CSTL | Director | Form 4 sale | 10,000 | $697k | 6.2% | Plan not stated | SEC |
| Jul 27, 2021 | CSTL | Director | Form 4 sale | 10,000 | $650k | 6.1% | Plan not stated | SEC |
| Jul 9, 2021 | CSTL | Director | Form 4 sale | 10,000 | $710k | 6.0% | Plan not stated | SEC |
| Apr 22, 2021 | CSTL | Director | Form 4 sale | 15,000 | $955k | 4.9% | Plan not stated | SEC |
| Apr 7, 2021 | CSTL | Director | Form 4 sale | 15,000 | $1.1M | 4.7% | Plan not stated | SEC |
| Mar 25, 2021 | CSTL | Director | Form 4 sale | 15,000 | $931k | 4.5% | Plan not stated | SEC |
| Mar 9, 2021 | CSTL | Director | Form 4 sale | 15,000 | $121M | 4.3% | Plan not stated | SEC |
| Feb 24, 2021 | CSTL | Director | Form 4 sale | 15,000 | $1.2M | 4.1% | Plan not stated | SEC |
| Feb 10, 2021 | CSTL | Director | Form 4 sale | 15,000 | $1.4M | 3.9% | Plan not stated | SEC |
| Jan 26, 2021 | CSTL | Director | Form 4 sale | 15,000 | $1.1M | 3.8% | Plan not stated | SEC |
| Jan 13, 2021 | CSTL | Director | Form 4 sale | 19,613 | $1.5M | 4.7% | Plan not stated | SEC |
| Dec 29, 2020 | CSTL | Director | Form 4 sale | 30,000 | $2.1M | 3.9% | Unusual | SEC |
| Dec 11, 2020 | CSTL | Director | Form 4 sale | 10,387 | $620k | 1.3% | Plan not stated | SEC |
| Nov 19, 2020 | CSTL | Director | Form 4 sale | 7,500 | $349k | 1.0% | Plan not stated | SEC |
| Nov 5, 2020 | CSTL | Director | Form 4 sale | 7,500 | $380k | 1.0% | Plan not stated | SEC |
| Oct 21, 2020 | CSTL | Director | Form 4 sale | 17,000 | $840k | 2.1% | Plan not stated | SEC |
| Oct 9, 2020 | CSTL | Director | Form 4 sale | 30,000 | $1.6M | 3.6% | Unusual | SEC |
| Sep 17, 2020 | CSTL | Director | Form 4 sale | 7,500 | $363k | 0.9% | Plan not stated | SEC |
| Sep 2, 2020 | CSTL | Director | Form 4 sale | 7,500 | $342k | 0.9% | Plan not stated | SEC |
| Aug 19, 2020 | CSTL | Director | Form 4 sale | 7,500 | $330k | 0.9% | Plan not stated | SEC |
| Aug 7, 2020 | CSTL | Director | Form 4 sale | 7,500 | $311k | 0.9% | Plan not stated | SEC |
| Jul 22, 2020 | CSTL | Director | Form 4 sale | 7,500 | $305k | 0.9% | Plan not stated | SEC |
| Jul 8, 2020 | CSTL | Director | Form 4 sale | 7,500 | $308k | 0.9% | Plan not stated | SEC |
| Jun 19, 2020 | CSTL | Director | Form 4 sale | 7,500 | $319k | 0.8% | Plan not stated | SEC |
| Jun 4, 2020 | CSTL | Director | Form 4 sale | 7,500 | $279k | 0.8% | Plan not stated | SEC |
| May 21, 2020 | CSTL | Director | Form 4 sale | 15,000 | $555k | 1.7% | Plan not stated | SEC |
| May 25, 2017 | ILMN | Director | Form 4 sale | 600 | $104k | 3.8% | Plan not stated | SEC |
| Apr 7, 2017 | ILMN | Director | Form 4 sale | 600 | $104k | 3.5% | Plan not stated | SEC |
| Mar 21, 2017 | ILMN | Director | Form 4 sale | 600 | $98k | 3.5% | Plan not stated | SEC |
| Feb 17, 2017 | ILMN | Director | Form 4 sale | 600 | $98k | 3.5% | Plan not stated | SEC |
| Jan 4, 2017 | ILMN | Director | Form 4 sale | 600 | $81k | 3.5% | Plan not stated | SEC |
| Dec 12, 2016 | ILMN | Director | Form 4 sale | 600 | $74k | 3.5% | Plan not stated | SEC |
| Nov 14, 2016 | ILMN | Director | Form 4 sale | 600 | $82k | 3.5% | Plan not stated | SEC |
| Oct 7, 2016 | ILMN | Director | Form 4 sale | 600 | $111k | 3.5% | Plan not stated | SEC |
| Sep 14, 2016 | ILMN | Director | Form 4 sale | 600 | $103k | 3.5% | Plan not stated | SEC |
| Aug 17, 2016 | ILMN | Director | Form 4 sale | 600 | $101k | 3.5% | Plan not stated | SEC |
| Mar 21, 2016 | ILMN | Director | Form 4 sale | 1,200 | $187k | 7.7% | Plan not stated | SEC |
| Feb 17, 2016 | ILMN | Director | Form 4 sale | 1,700 | $263k | 10.6% | Plan not stated | SEC |
| Jan 4, 2016 | ILMN | Director | Form 4 sale | 1,700 | $311k | 10.6% | Plan not stated | SEC |
| Dec 10, 2015 | CORT | Director | Form 4 sale | 20,000 | $97k | 10.1% | Plan not stated | SEC |
| Dec 10, 2015 | ILMN | Director | Form 4 sale | 1,700 | $310k | 10.6% | Plan not stated | SEC |
| Nov 24, 2015 | CORT | Director | Form 4 sale | 40,000 | $200k | 16.8% | Plan not stated | SEC |
| Nov 10, 2015 | ILMN | Director | Form 4 sale | 1,700 | $262k | 10.6% | Plan not stated | SEC |
| Oct 7, 2015 | ILMN | Director | Form 4 sale | 1,700 | $248k | 10.6% | Plan not stated | SEC |
| Sep 16, 2015 | CORT | Director | Form 4 sale | 20,000 | $99k | 7.8% | Plan not stated | SEC |
| Sep 14, 2015 | ILMN | Director | Form 4 sale | 1,700 | $347k | 10.6% | Plan not stated | SEC |
| Aug 27, 2015 | CORT | Director | Form 4 sale | 20,000 | $95k | 7.2% | Plan not stated | SEC |
| Aug 17, 2015 | ILMN | Director | Form 4 sale | 1,700 | $354k | 10.6% | Plan not stated | SEC |
| Jul 21, 2015 | CORT | Director | Form 4 sale | 20,000 | $103k | 6.7% | Plan not stated | SEC |
| Jul 6, 2015 | ILMN | Director | Form 4 sale | 1,700 | $373k | 10.6% | Plan not stated | SEC |
| Jun 24, 2015 | CORT | Director | Form 4 sale | 20,000 | $135k | 6.3% | Plan not stated | SEC |
| Jun 24, 2015 | ILMN | Director | Form 4 sale | 1,700 | $376k | 10.6% | Plan not stated | SEC |
| May 29, 2015 | ILMN | Director | Form 4 sale | 1,700 | $351k | 10.6% | Plan not stated | SEC |
| Apr 8, 2015 | ILMN | Director | Form 4 sale | 1,700 | $315k | 12.0% | Plan not stated | SEC |
| Mar 16, 2015 | ILMN | Director | Form 4 sale | 1,700 | $330k | 12.0% | Plan not stated | SEC |
| Dec 8, 2014 | ILMN | Director | Form 4 sale | 1,600 | $304k | 11.4% | Plan not stated | SEC |
| Nov 13, 2014 | ILMN | Director | Form 4 sale | 2,100 | $392k | 14.4% | Plan not stated | SEC |
| Oct 30, 2014 | ILMN | Director | Form 4 sale | 2,100 | $403k | 14.4% | Plan not stated | SEC |
| Oct 13, 2014 | ILMN | Director | Form 4 sale | 2,100 | $319k | 14.4% | Plan not stated | SEC |
| Oct 1, 2014 | ILMN | Director | Form 4 sale | 2,100 | $334k | 14.4% | Plan not stated | SEC |
| Sep 15, 2014 | ILMN | Director | Form 4 sale | 2,100 | $354k | 14.4% | Plan not stated | SEC |
| Sep 3, 2014 | ILMN | Director | Form 4 sale | 2,100 | $378k | 14.4% | Plan not stated | SEC |
| Aug 22, 2014 | ILMN | Director | Form 4 sale | 2,100 | $362k | 14.4% | Plan not stated | SEC |
| Aug 4, 2014 | ILMN | Director | Form 4 sale | 2,100 | $336k | 14.4% | Plan not stated | SEC |
| Jul 23, 2014 | ILMN | Director | Form 4 sale | 2,100 | $374k | 14.4% | Plan not stated | SEC |
| Jul 8, 2014 | ILMN | Director | Form 4 sale | 2,100 | $363k | 14.4% | Plan not stated | SEC |
| Jun 27, 2014 | ILMN | Director | Form 4 sale | 2,100 | $360k | 14.4% | Plan not stated | SEC |
| Jun 12, 2014 | ILMN | Director | Form 4 sale | 2,100 | $359k | 14.4% | Plan not stated | SEC |
| May 27, 2014 | ILMN | Director | Form 4 sale | 2,100 | $334k | 17.5% | Plan not stated | SEC |
| May 14, 2014 | ILMN | Director | Form 4 sale | 2,100 | $308k | 17.5% | Plan not stated | SEC |
| May 2, 2014 | ILMN | Director | Form 4 sale | 2,100 | $293k | 17.5% | Plan not stated | SEC |
| Apr 15, 2014 | ILMN | Director | Form 4 sale | 2,100 | $276k | 17.5% | Plan not stated | SEC |
| Apr 4, 2014 | ILMN | Director | Form 4 sale | 2,100 | $291k | 17.5% | Plan not stated | SEC |
| Mar 19, 2014 | ILMN | Director | Form 4 sale | 2,100 | $338k | 17.5% | Plan not stated | SEC |
| Mar 6, 2014 | ILMN | Director | Form 4 sale | 2,100 | $368k | 17.5% | Plan not stated | SEC |
| Mar 1, 2012 | AMYLIN PHARMACEUTICALS INC | President & Chief Executive Of | Form 4 sale | 1,539 | $26k | 2.4% | Plan not stated | SEC |
| Jul 18, 2011 | ILMN | Director | Form 4 sale | 4,000 | $283k | 43.3% | Unusual | SEC |
| Jun 17, 2011 | ILMN | Director | Form 4 sale | 4,000 | $288k | 43.3% | Unusual | SEC |
| May 18, 2011 | ILMN | Director | Form 4 sale | 5,000 | $366k | 48.8% | Unusual | SEC |
| Apr 18, 2011 | ILMN | Director | Form 4 sale | 4,000 | $265k | 51.3% | Unusual | SEC |
| Mar 17, 2011 | ILMN | Director | Form 4 sale | 4,000 | $252k | 51.3% | Unusual | SEC |
| Dec 9, 2010 | ILMN | Director | Form 4 sale | 6,400 | $402k | 78.0% | Unusual | SEC |
| Nov 2, 2010 | ILMN | Director | Form 4 sale | 6,400 | $348k | 76.8% | Unusual | SEC |
| Oct 4, 2010 | ILMN | Director | Form 4 sale | 6,400 | $318k | 76.8% | Unusual | SEC |
| Sep 10, 2010 | ILMN | Director | Form 4 sale | 6,400 | $284k | 76.8% | Unusual | SEC |
| Aug 10, 2010 | ILMN | Director | Form 4 sale | 6,400 | $297k | 76.8% | Unusual | SEC |
| Mar 2, 2010 | ILMN | Director | Form 4 sale | 3,600 | $137k | 62.8% | Unusual | SEC |
| Feb 3, 2010 | ILMN | Director | Form 4 sale | 3,600 | $136k | 47.4% | Unusual | SEC |
| Jan 6, 2010 | ILMN | Director | Form 4 sale | 3,600 | $114k | 47.4% | Unusual | SEC |
| Dec 3, 2009 | ILMN | Director | Form 4 sale | 3,600 | $105k | 47.4% | Unusual | SEC |
| Nov 5, 2009 | ILMN | Director | Form 4 sale | 3,600 | $118k | 47.4% | Unusual | SEC |
| Oct 1, 2009 | ILMN | Director | Form 4 sale | 3,600 | $150k | 47.4% | Unusual | SEC |
| Sep 2, 2009 | ILMN | Director | Form 4 sale | 3,600 | $127k | 47.4% | Unusual | SEC |
| Aug 5, 2009 | ILMN | Director | Form 4 sale | 3,600 | $132k | 47.4% | Unusual | SEC |
| Jul 9, 2009 | ILMN | Director | Form 4 sale | 3,600 | $116k | 47.4% | Unusual | SEC |
| Jun 4, 2009 | ILMN | Director | Form 4 sale | 3,600 | $140k | 47.4% | Unusual | SEC |
| Oct 21, 2008 | ILMN | Director | Form 4 sale | 6,000 | $196k | 75.0% | Unusual | SEC |
| Aug 19, 2008 | ILMN | Director | Form 4 sale | 3,000 | $277k | 75.0% | Unusual | SEC |
| Jul 23, 2008 | ILMN | Director | Form 4 sale | 3,000 | $273k | 75.0% | Unusual | SEC |
| Jun 18, 2008 | ILMN | Director | Form 4 sale | 3,000 | $245k | 75.0% | Unusual | SEC |
| May 7, 2007 | AMYLIN PHARMACEUTICALS INC | President & Chief Exec Officer | Form 4 sale | 2,894 | $121k | 7.1% | Plan not stated | SEC |
| Apr 9, 2007 | AMYLIN PHARMACEUTICALS INC | President & Chief Exec Officer | Form 4 sale | 2,500 | $97k | 61.0% | Unusual | SEC |
| Mar 7, 2007 | AMYLIN PHARMACEUTICALS INC | President & Chief Operating | Form 4 sale | 2,500 | $93k | 31.7% | Unusual | SEC |
| Feb 7, 2007 | AMYLIN PHARMACEUTICALS INC | President & Chief Operating | Form 4 sale | 3,500 | $142k | 30.7% | Unusual | SEC |
| Jan 9, 2007 | AMYLIN PHARMACEUTICALS INC | President & Chief Operating | Form 4 sale | 2,500 | $96k | 18.0% | Plan not stated | SEC |
| Dec 7, 2006 | AMYLIN PHARMACEUTICALS INC | President & Chief Operating | Form 4 sale | 2,500 | $98k | 50.0% | Unusual | SEC |
| Nov 7, 2006 | AMYLIN PHARMACEUTICALS INC | President & Chief Operating | Form 4 sale | 3,000 | $134k | 37.5% | Unusual | SEC |
| Oct 6, 2006 | AMYLIN PHARMACEUTICALS INC | President & Chief Operating | Form 4 sale | 3,000 | $128k | 27.3% | Unusual | SEC |
| Sep 8, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 2,111 | $93k | 15.7% | Plan not stated | SEC |
| Aug 7, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 3,000 | $142k | 18.3% | Plan not stated | SEC |
| Jul 10, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 3,500 | $174k | 17.6% | Plan not stated | SEC |
| Jun 7, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 3,000 | $135k | 13.1% | Plan not stated | SEC |
| May 5, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 3,000 | $130k | 11.6% | Plan not stated | SEC |
| Apr 7, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 3,000 | $138k | 10.4% | Plan not stated | SEC |
| Mar 7, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 2,000 | $85k | 7.5% | Plan not stated | SEC |
| Feb 23, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 12,552 | $515k | 32.1% | Unusual | SEC |
| Feb 21, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 12,551 | $498k | 32.1% | Unusual | SEC |
| Feb 16, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 12,551 | $480k | 32.1% | Unusual | SEC |
| Feb 7, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 2,000 | $76k | 7.3% | Plan not stated | SEC |
| Jan 9, 2006 | AMYLIN PHARMACEUTICALS INC | Chief Operating Officer | Form 4 sale | 2,000 | $86k | 6.8% | Plan not stated | SEC |